UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 167

Sortiert nach

Diagnosis of heart failure with preserved ejection fraction. Not seeing the forest for the trees or a step to precision medicine?

The International Journal of Cardiovascular Imaging, 2021-08, Vol.37 (8), p.2497-2499

2021

Volltextzugriff (PDF)

Somatic symptom profile in patients with chronic heart failure with and without depressive comorbidity

Frontiers in psychiatry, 2024-03, Vol.15, p.1356497-1356497

2024

Volltextzugriff (PDF)

Anxiety and self-care behaviour in patients with chronic systolic heart failure: A multivariate model

European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology, 2018-02, Vol.17 (2), p.170-177

2018

Volltextzugriff (PDF)

A multi-vendor, multi-center study on reproducibility and comparability of fast strain-encoded cardiovascular magnetic resonance imaging

The International Journal of Cardiovascular Imaging, 2020-05, Vol.36 (5), p.899-911

2020

Volltextzugriff (PDF)

Case report: Case series of isolated acute pericarditis after SARS-CoV-2 vaccinations

Frontiers in cardiovascular medicine, 2022-08, Vol.9

2022

Volltextzugriff (PDF)

Depletion of cardiac catecholamine stores impairs cardiac norepinephrine re-uptake by downregulation of the norepinephrine transporter

PloS one, 2017-03, Vol.12 (3), p.e0172070-e0172070

2017

Volltextzugriff (PDF)

Depression increasingly predicts mortality in the course of congestive heart failure

European journal of heart failure, 2005-03, Vol.7 (2), p.261-267

2005

Volltextzugriff (PDF)

Essential role of sympathetic endothelin A receptors for adverse cardiac remodeling

Proceedings of the National Academy of Sciences - PNAS, 2014-09, Vol.111 (37), p.13499-13504

2014

Volltextzugriff (PDF)

Predictors of persistent symptoms after mRNA SARS-CoV-2 vaccine-related myocarditis (myovacc registry)

Frontiers in cardiovascular medicine, 2023-06, Vol.10, p.1204232-1204232

2023

Volltextzugriff (PDF)

Symptom Severity and Health-Related Quality of Life in Patients with Atrial Fibrillation: Findings from the Observational ARENA Study

Journal of clinical medicine, 2022-02, Vol.11 (4), p.1140

2022

Volltextzugriff (PDF)

Aldosterone augments Na+-induced reduction of cardiac norepinephrine reuptake

American journal of physiology. Heart and circulatory physiology, 2014-10, Vol.307 (8), p.H1169-H1177

2014

Volltextzugriff (PDF)

Differential expression of cardiac neurotrophic factors and sympathetic nerve ending abnormalities within the failing heart

Journal of molecular and cellular cardiology, 2008-02, Vol.44 (2), p.380-387

2008

Volltextzugriff (PDF)

Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure

Journal of the American College of Cardiology, 2002-05, Vol.39 (10), p.1615-1622

2002

Volltextzugriff (PDF)

Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial

Circulation (New York, N.Y.), 2021-10, Vol.144 (16), p.1284-1294

2021

Volltextzugriff (PDF)

Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial

Circulation (New York, N.Y.), 2021-01, Vol.143 (4), p.326-336

2021

Volltextzugriff (PDF)

Self-care and depression in patients with chronic heart failure

Heart & lung, 2009-09, Vol.38 (5), p.392-397

2009

Volltextzugriff (PDF)

Spironolactone Preserves Cardiac Norepinephrine Reuptake in Salt-Sensitive Dahl Rats

Endocrinology (Philadelphia), 2006-05, Vol.147 (5), p.2526-2534

2006

Volltextzugriff (PDF)

Pharmacy‐based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM‐CHF randomized controlled trial

European journal of heart failure, 2019-08, Vol.21 (8), p.1012-1021

2019

Volltextzugriff (PDF)

The Neuronal Norepinephrine Transporter in Experimental Heart Failure: Evidence for a Posttranscriptional Downregulation

Journal of molecular and cellular cardiology, 2001-03, Vol.33 (3), p.461-472

2001

Volltextzugriff (PDF)

Significance of psychosocial factors in cardiology: update 2018: Position paper of the German Cardiac Society

Clinical research in cardiology, 2019-11, Vol.108 (11), p.1175-1196

2019

Volltextzugriff (PDF)

The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction

JACC. Heart failure, 2015-06, Vol.3 (6), p.429-441

2015

Volltextzugriff (PDF)

Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial

Circulation. Heart failure, 2011-05, Vol.4 (3), p.324-331

2011

Volltextzugriff (PDF)

PREDICTORS OF PERSISTENT SYMPTOMS AFTER MRNA SARS-COV-2 VACCINE-RELATED MYOCARDITIS (MYOVACC REGISTRY)

Journal of the American College of Cardiology, 2023-03, Vol.81 (8), p.1379-1379

2023

Volltextzugriff (PDF)

1 – 25 von 167

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(159)

Publikationsform

Sprache

Englisch
(159)
Japanisch
(19)
Deutsch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Diagnosis of heart failure with preserved ejection fraction. Not seeing the forest for the trees or a step to precision medicine?

Somatic symptom profile in patients with chronic heart failure with and without depressive comorbidity

Anxiety and self-care behaviour in patients with chronic systolic heart failure: A multivariate model

Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) program

A multi-vendor, multi-center study on reproducibility and comparability of fast strain-encoded cardiovascular magnetic resonance imaging

Case report: Case series of isolated acute pericarditis after SARS-CoV-2 vaccinations

Depletion of cardiac catecholamine stores impairs cardiac norepinephrine re-uptake by downregulation of the norepinephrine transporter

Depression increasingly predicts mortality in the course of congestive heart failure

Essential role of sympathetic endothelin A receptors for adverse cardiac remodeling

Predictors of persistent symptoms after mRNA SARS-CoV-2 vaccine-related myocarditis (myovacc registry)

Symptom Severity and Health-Related Quality of Life in Patients with Atrial Fibrillation: Findings from the Observational ARENA Study

Aldosterone augments Na+-induced reduction of cardiac norepinephrine reuptake

Differential expression of cardiac neurotrophic factors and sympathetic nerve ending abnormalities within the failing heart

Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure

Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial

Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial

Self-care and depression in patients with chronic heart failure

Spironolactone Preserves Cardiac Norepinephrine Reuptake in Salt-Sensitive Dahl Rats

Pharmacy‐based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM‐CHF randomized controlled trial

Rationale and design of the DIGIT‐HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double‐blind, placebo‐controlled study

The Neuronal Norepinephrine Transporter in Experimental Heart Failure: Evidence for a Posttranscriptional Downregulation

Significance of psychosocial factors in cardiology: update 2018: Position paper of the German Cardiac Society

The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction

Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial

PREDICTORS OF PERSISTENT SYMPTOMS AFTER MRNA SARS-COV-2 VACCINE-RELATED MYOCARDITIS (MYOVACC REGISTRY)

Suchergebnisse filtern